![]() |
By Evelyn Pringle (about the author) Page 4 of 4 page(s)
"Among many other things," he said, "Dr. von Eschenbach has presided over the FDA as it issued a new rule that prevents Americans from filing lawsuits against drug companies if they or a loved one become seriously ill or die as the result of a particular drug."
"And in just the last few days," Rep. Hinchey reported, "the FDA has approved numerous waivers for panelists on its advisory boards who have financial conflicts of interest with drugs and devices they are reviewing."
Houston attorney, Robert Kwok, makes the point that "fortunately, there are just two years left in this administration, so Dr von Eschenbach's term may be short."
"But he can still do a lot of damage in that time," he warns, "to the rights of Americans, their health, and their privacy."
Families seeking legal advice for infants born with birth defects to mothers who were prescribed Celexa during pregnancy can contact Robert Kwok & Associates, LLP at (713) 773-3380; http://www.kwoklaw.com/about.php
Evelyn Pringle
evelyn-pringle@sbcglobal.net
(Evelyn Pringle is a columnist for OpEd News and an investigative journalist focused on exposing corruption in government and corporate America)
(This article is written as part of a series on pharmaceutical litigation and is sponsored by Robert Kwok & Associated, LLP)
The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.
Contact Author |
Contact Editor |
View Authors' Articles |
| 4 comments |
Want to post your own comment on this Article?
|
||||
Tell a Friend:
|
Copyright © 2002-2009, OpEdNews |